Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share - Schedule of anti-dilutive securities (Details)

v3.24.1.1.u2
Loss Per Share - Schedule of anti-dilutive securities (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 15,128,518 12,542,165
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 4,103,267 2,801,703
Stock options and stock appreciation rights    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 9,338,865 9,477,307
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 1,686,386 263,155